Excellent 4.6 out of 5
Solvents & Industrial Byproducts

2-Methylhippuric Acid (2MHA) Environmental Toxin Test

This urine test measures 2‑methylhippuric acid to detect and quantify recent o‑xylene (solvent) exposure. Catching exposure early helps you prevent headaches, dizziness, respiratory irritation, and longer‑term nervous system, liver, and kidney damage from solvent overexposure.

With Superpower, you have access to a comprehensive range of biomarker tests.

Test for 2-Methylhippuric Acid (2MHA)
Cancel anytime
HSA/FSA eligible
Results in a week
Physician reviewed

Every result is checked

·
CLIA-certified labs

Federal standard for testing

·
HIPAA compliant

Your data is 100% secure

Key Insights

  • See your current exposure to o‑xylene by measuring its urine metabolite, 2‑methylhippuric acid (2MHA), and how it compares with typical population levels.
  • Identify meaningful exposure patterns and potential sources from everyday life, like fresh paint or solvents, fuel and exhaust, home renovations, nail salons, or poorly ventilated indoor air.
  • Clarify whether xylene exposure could be contributing to symptom clusters such as headaches, lightheadedness, eye or throat irritation, or system stress in the nervous and liver systems.
  • Support reproductive planning or pregnancy safety by checking for elevations during sensitive life stages when developing brains are more vulnerable.
  • Track trends over time after changing products, improving ventilation, or reducing occupational contact to see if adjustments are reflected in your body.
  • Inform conversations with your clinician about whether additional evaluations, workplace considerations, or targeted reduction strategies are appropriate.

What is 2‑Methylhippuric Acid (2MHA)?

2‑Methylhippuric acid is a breakdown product your body makes after exposure to o‑xylene, a common volatile organic compound found in paint thinners, spray paints, adhesives, printing inks, gasoline, and some industrial and salon settings. Xylenes evaporate easily, so the main exposure pathway is breathing indoor or occupational air where these solvents are used. Skin contact and accidental ingestion are possible but less common in everyday life. Labs typically measure 2MHA in urine using mass spectrometry to capture recent exposure. Because it clears within hours to a day or two, a single test reflects short‑term exposure rather than long‑term body burden.

Why it matters: o‑Xylene is lipid‑soluble, so it distributes to tissues like the brain before the liver transforms it. Liver enzymes convert o‑xylene to methyl‑benzoic acids, then conjugate with glycine to form 2MHA, which the kidneys excrete in urine. At high air levels, xylenes can irritate eyes and airways and act on the central nervous system, producing headaches, dizziness, and fatigue. Repeated or higher occupational exposure can place additional demand on liver and kidney clearance pathways. Most community exposures are low, but biomonitoring programs use methylhippuric acids as reliable markers of xylene contact, with ongoing research on the health relevance of persistent low‑level exposure.

Why Is It Important to Test For 2‑Methylhippuric Acid (2MHA)?

Testing connects the dots between what you smell or touch and what your body has actually absorbed. Xylenes move quickly from air to blood and then into tissues, so your brain may “feel” exposure before you notice the source. Urine 2MHA provides an objective snapshot of that contact. Results can help separate incidental encounters, like a brief visit to a freshly painted room, from sustained exposure, such as a week of home renovation, daily time at a busy fuel station, or work in auto repair, printing, or beauty care environments. When symptoms like headaches, lightheadedness, sore throat, or unusual fatigue cluster around certain locations or tasks, a measured rise in 2MHA can anchor those patterns in data. For those planning pregnancy or already pregnant, a check is reasonable during periods of known solvent contact. Solvents like xylene can cross the placenta, and although most household exposures are low, the developing nervous system is more sensitive than the adult nervous system.

The test also clarifies the role of environment relative to other health factors. Xylene does not typically bioaccumulate for years the way some metals or PFAS do. Instead, levels rise and fall with recent contact and ventilation. That makes trend testing a powerful tool. If 2MHA decreases after you swap products or improve airflow, that change is a real‑world confirmation that exposure dropped. For people in higher‑exposure jobs, periodic checks can inform discussions about protective practices or workplace controls. Results are best interpreted alongside other solvent biomarkers where relevant, because indoor and occupational air often contains a mixture. For example, toluene is reflected by hippuric acid and ethylbenzene by mandelic and phenylglyoxylic acids, while 2MHA specifically tracks o‑xylene. Population surveys and occupational guidelines provide context for what is common, what is elevated for a given setting, and when follow‑up is worth considering. In short, the number is not a diagnosis, but it is a meaningful signal that links your lived environment to your biology.

What Insights Will I Get From a 2‑Methylhippuric Acid (2MHA) Test?

Labs usually report 2MHA using population‑based reference ranges and, for urine, often correct for creatinine to account for hydration differences. Because this is an environmental toxin marker, lower values are generally preferable when feasible. Interpretation improves when you know what you did in the 24 to 48 hours before your sample and when you repeat testing to see trends rather than relying on a single point.

Relatively lower values usually indicate limited recent contact with o‑xylene and a lower likelihood of short‑term irritation or stress on clearance pathways. In everyday terms, that looks like spending little time around fresh paint or solvents, fueling and leaving promptly, and working in spaces with adequate airflow. In pregnancy and early childhood, lower levels are desirable because developing brains are more sensitive to solvent effects.

Relatively higher values can indicate a recent or ongoing exposure that is outpacing your environment’s ability to dilute or ventilate. That may place added demand on the liver’s phase I and phase II metabolism and on the kidneys for excretion, and it can align with symptoms like headaches, throat or eye irritation, or feeling “foggy,” especially after time in specific rooms or at work. Because 2MHA reflects short‑term exposure, confirmation with repeat testing and context is important before drawing conclusions.

Big picture, your 2MHA result is most meaningful when viewed alongside other volatile solvent metabolites, general health markers, and your day‑to‑day patterns. Over time, that combination separates transient spikes from persistent exposure, helps identify the true sources in your routine, and supports smarter, safer choices in partnership with your clinician. A few practical caveats improve accuracy: spot urine samples reflect timing and hydration, creatinine correction can vary with muscle mass, and some labs report the sum of methylhippuric acids while others report 2MHA specifically. Despite these nuances, 2MHA remains a well‑accepted, specific marker of o‑xylene contact used in biomonitoring and occupational health, with ongoing studies refining what levels mean for long‑term health.

Superpower also tests for

See more diseases

Frequently Asked Questions About

What is a 2-Methylhippuric Acid (2MHA) test?

This test measures urinary 2‑methylhippuric acid, a metabolite and exposure marker of o‑xylene.

It is used to estimate recent occupational or environmental xylene exposure (typically via inhalation or dermal absorption), as 2‑MHA reflects xylene uptake and is rapidly excreted in urine within hours to a day.

Should I test for 2-Methylhippuric Acid (2MHA)?

Testing for 2‑Methylhippuric Acid (2MHA) — a urinary metabolite indicating xylene/volatile organic compound exposure — can be useful if you suspect contacts with solvents or fuels; it matters for health and longevity because xylene and related VOCs contribute to acute central nervous system effects and add to cumulative toxic and oxidative stress that may influence long‑term organ, reproductive, and functional health.

Common sources include paints, solvents, gasoline/vehicle exhaust, adhesives and other industrial chemical processes; possible health impacts range from headaches, dizziness and respiratory irritation to, with repeated or high exposures, potential liver, kidney, reproductive or neurobehavioral effects; testing helps quantify recent exposure so you can target controls (ventilation, substitution, PPE, behavioral changes) and lower cumulative exposure that could affect long‑term health.

Those who benefit most are people with high environmental or occupational exposure risk (painters, mechanics, refinery or chemical workers), residents near heavy traffic or industrial sites, individuals with unexplained neurocognitive or chronic symptoms, people concerned about fertility or thyroid issues, and those focused on optimizing detox capacity or longevity.

How often should I test for 2-Methylhippuric Acid (2MHA)?

Typically you would test once to establish a baseline for 2‑Methylhippuric Acid (2MHA), then do periodic follow‑up testing if levels are elevated or if exposure risks change; for example, retest after changing household products, after workplace task changes that involve solvents, following detoxification efforts, or after remediation of an environmental source—the exact interval (weeks to months) depends on initial levels and ongoing exposure risk.

What can affect 2-Methylhippuric Acid (2MHA) test results?

2‑Methylhippuric acid (2MHA) test results can be affected by timing of sample collection (levels vary with time since exposure), recent exposure from food, air, water or consumer products, individual metabolism (age, genetics, liver or kidney function), hydration status (urine dilution), and the sample type collected (urine versus blood); certain medications or dietary supplements may also influence readings.

Are there any preparations needed before testing 2-Methylhippuric Acid (2MHA) levels?

No special dietary fasting is required before a 2‑methylhippuric acid (2MHA) urine test. Laboratories may accept either a spot/“random” urine sample or a first‑morning sample depending on the test protocol, so follow the clinician or lab instructions — a first‑morning sample is sometimes used for baseline consistency but is not universally required.

It is advisable, if possible, to avoid non‑occupational exposure to xylene-containing products (e.g., solvent‑based paints, adhesives, aerosols, some plastics and personal‑care products) for about 24–48 hours before sampling to reduce confounding results, and to note any recent use or environmental contact (plastics, personal care items, pesticides, smoking, solvent use, etc.) when you provide the sample so the clinician can interpret results accurately. Follow any additional directions from the testing laboratory or occupational health provider.

How accurate is 2-Methylhippuric Acid (2MHA) testing?

2‑Methylhippuric acid (2MHA) is a well‑established urinary biomarker that is generally reliable for indicating recent exposure to its parent chemicals; it reflects short‑term exposure (typically the previous day or so) rather than cumulative long‑term body burden. Because 2MHA is an excreted metabolite with a relatively short biological half‑life, measured concentrations show recent intake or workplace exposure more than chronic accumulation.

Accuracy depends on several controllable factors: timing of urine collection relative to exposure (samples taken too early or long after exposure can underestimate levels), the laboratory method used (mass spectrometry–based methods such as GC‑MS or LC‑MS/MS provide the best sensitivity and specificity), and consistent collection and handling (spot vs. timed samples, creatinine or specific‑gravity correction, proper storage and shipment). Interindividual differences in metabolism and hydration can also affect concentrations, so results are best interpreted with timing, method, and sampling consistency in mind.

What happens if my 2-Methylhippuric Acid (2MHA) levels are outside the optimal or reference range?

Higher-than-reference 2‑Methylhippuric Acid (2MHA) most commonly indicates recent or ongoing exposure to xylene or related solvents (for example from certain jobs, products, or indoor environments) or slower elimination from the body (due to timing of the sample, individual metabolism, or impaired liver/kidney function). Elevated 2MHA suggests a greater internal exposure or body burden, not a diagnosis by itself, and may prompt steps to reduce or remove the source of exposure.

Results must be interpreted in context — alongside other toxin measurements, clinical symptoms, occupational/environmental history, and health markers (liver/kidney tests, etc.). A single out‑of‑range value can reflect a recent exposure or lab variability, so clinicians often repeat testing, assess exposure sources, and consider medical evaluation before drawing conclusions or taking action.

How do I interpret my 2-Methylhippuric Acid (2MHA) test results?

2‑Methylhippuric acid (2MHA) in urine is a metabolite that indicates recent exposure to xylene-type solvents; values reported above the laboratory’s reference range or reporting limit generally reflect a recent or ongoing exposure, while nondetectable or low levels suggest little or no recent exposure. Interpret results using creatinine‑corrected or specific‑gravity–adjusted values (the lab should provide this) because urine dilution strongly affects concentration, and remember that 2MHA is typically excreted within about 24–48 hours of exposure, so single measurements reflect recent exposures rather than long‑term body burden.

Place your 2MHA result in context: compare repeat measurements to look for trends over time (persistent or rising levels are more meaningful than a single isolated elevation) and review it alongside related toxin markers and body‑system indicators — for example other solvent metabolites, liver enzymes, kidney function tests, and oxidative‑stress or inflammation biomarkers — as well as documented exposure history (work tasks, incidents, or environmental sources). Use trends plus clinical context to guide follow‑up (exposure reduction, workplace controls, or medical evaluation) and consult occupational‑health or medical professionals for interpretation and action.

How it works

1

Test your whole body

Get a comprehensive blood draw at one of our 3,000+ partner labs or from the comfort of your own home.

2

An Actionable Plan

Easy to understand results & a clear action plan with tailored recommendations on diet, lifestyle changes, supplements and pharmaceuticals.

3

A Connected Ecosystem

You can book additional diagnostics, buy curated supplements for 20% off & pharmaceuticals within your Superpower dashboard.

Superpower tests more than 
100+ biomarkers & common symptoms

Developed by world-class medical professionals

Supported by the world’s top longevity clinicians and MDs.

Dr Anant Vinjamoori

Superpower Chief Longevity Officer, Harvard MD & MBA

A smiling woman wearing a white coat and stethoscope poses for a portrait.

Dr Leigh Erin Connealy

Clinician & Founder of The Centre for New Medicine

Man in a black medical scrub top smiling at the camera.

Dr Abe Malkin

Founder & Medical Director of Concierge MD

Dr Robert Lufkin

UCLA Medical Professor, NYT Bestselling Author

membership

$17

/month
Billed annually at $199
A smartphone displays health app results, showing biomarker summary, superpower score, and biological age details.
A website displays a list of most ordered products including a ring, vitamin spray, and oil.
A smartphone displays health app results, showing biomarker summary, superpower score, and biological age details.A tablet screen shows a shopping website with three most ordered products: a ring, supplement, and skincare oil.
What could cost you $15,000 is $199

Superpower
Membership

Your membership includes one comprehensive blood draw each year, covering 100+ biomarkers in a single collection
One appointment, one draw for your annual panel.
100+ labs tested per year
A personalized plan that evolves with you
Get your biological age and track your health over a lifetime
$
17
/month
billed annually
Flexible payment options
Four credit card logos: HSA/FSA Eligible, American Express, Visa, and Mastercard.
Start testing
Cancel anytime
HSA/FSA eligible
Results in a week
Pricing may vary for members in New York and New Jersey **

Finally, healthcare that looks at the whole you